骨再生用生物补丁
|
By LabMedica International staff writers Posted on 12 Dec 2013 |

图片:University of Iowa 的研究人员发明了一种生物补丁,促进缺失或受损的骨组织再生。如照片(上方)所示的补丁令缺失的头骨再生(照片由 Satheesh Elangovan 提供)
科学家们发明了一种生物补丁,令缺失或受损的骨组织再生,即通过 DNA 加入纳米粒子把成骨指令正确传递给细胞。
这是一项创新性研究,研究人员使用编码血小板源生长因子(被称为血小板源生长因子 B 亚单位,PDGF-B)的 DNA 片段直接将成骨指令传递给体内现有骨细胞,允许这些细胞生成蛋白质,令更多骨组织生成。早期努力从体外重复给予此类物质,这种操作费用昂贵,频次密集,贯穿复杂的复制过程。
“我们将 DNA 传递给细胞,令细胞生成蛋白质,这就是提高骨再生的蛋白质生成方式,”University of Iowa’s (UI; Iowa City, USA) College of Pharmacy 的教授,计划于 2014 年 1 月刊发于《生物材料》(Biomaterial)期刊的论文的联合通讯作者 Aliasger Salem 博士说道。
研究者以胶原支架为起点。然后将带有合成创新质粒的生物补丁加载至支架上,其中的质粒能为成骨提供基因指令。然后将支架插入受试动物 5 mm x 2 mm 的头骨缺失区。4 周后,研究人员对插入含生物补丁支架、无质粒支架或未植入的受试动物情况进行比较。
加入质粒的生物补丁令受试动物涉及部位的骨骼和软组织增长量达单纯支架植入者的44倍以上,比未植入的受试动物高14倍。研究人员报告:外观和横截面扫描显示,质粒编码支架刺激足量新骨生成,几近令创口区域闭合。
质粒进入体内已有的骨细胞(通常位于受损部位周围,环绕支架)发挥作用。研究团队使用聚合物缩小粒子的大小,并使质粒带正电荷,令其更容易被现有骨细胞所接受。研究人员还强调,采用的传输策略并非借助病毒完成,这就意味着这些质粒不太可能引发非预期性免疫应答,但是能够生成大量骨细胞,从而降低操作的成本。
下一个研究阶段中,科学家们将建立生物平台,刺激新的血管生长,满足扩展和维持骨生长的需要。
Related Links:
University of Iowa
这是一项创新性研究,研究人员使用编码血小板源生长因子(被称为血小板源生长因子 B 亚单位,PDGF-B)的 DNA 片段直接将成骨指令传递给体内现有骨细胞,允许这些细胞生成蛋白质,令更多骨组织生成。早期努力从体外重复给予此类物质,这种操作费用昂贵,频次密集,贯穿复杂的复制过程。
“我们将 DNA 传递给细胞,令细胞生成蛋白质,这就是提高骨再生的蛋白质生成方式,”University of Iowa’s (UI; Iowa City, USA) College of Pharmacy 的教授,计划于 2014 年 1 月刊发于《生物材料》(Biomaterial)期刊的论文的联合通讯作者 Aliasger Salem 博士说道。
研究者以胶原支架为起点。然后将带有合成创新质粒的生物补丁加载至支架上,其中的质粒能为成骨提供基因指令。然后将支架插入受试动物 5 mm x 2 mm 的头骨缺失区。4 周后,研究人员对插入含生物补丁支架、无质粒支架或未植入的受试动物情况进行比较。
加入质粒的生物补丁令受试动物涉及部位的骨骼和软组织增长量达单纯支架植入者的44倍以上,比未植入的受试动物高14倍。研究人员报告:外观和横截面扫描显示,质粒编码支架刺激足量新骨生成,几近令创口区域闭合。
质粒进入体内已有的骨细胞(通常位于受损部位周围,环绕支架)发挥作用。研究团队使用聚合物缩小粒子的大小,并使质粒带正电荷,令其更容易被现有骨细胞所接受。研究人员还强调,采用的传输策略并非借助病毒完成,这就意味着这些质粒不太可能引发非预期性免疫应答,但是能够生成大量骨细胞,从而降低操作的成本。
下一个研究阶段中,科学家们将建立生物平台,刺激新的血管生长,满足扩展和维持骨生长的需要。
Related Links:
University of Iowa
Latest Biotech News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more






 Analyzer.jpg)
